The Influence of Nutritional Status on the Response to HAART in HIV-Infected Children in South Africa

被引:25
作者
Naidoo, Reene [1 ]
Rennert, Wolfgang [1 ]
Lung, Audrey [1 ]
Naidoo, Kimesh [2 ,3 ]
McKerrow, Neil
机构
[1] Georgetown Univ Hosp, Dept Pediat, Washington, DC 20007 USA
[2] Univ KwaZulu Natal, Dept Paediat, Nelson R Mandela Sch Med, Durban, South Africa
[3] Univ KwaZulu Natal, Dept Paediat, Nelson R Mandela Sch Med, Durban, South Africa
关键词
HIV; children; malnutrition; HAART; Africa; ANTIRETROVIRAL THERAPY; GROWTH; LAMIVUDINE; INDINAVIR; MORTALITY; EFFICACY; OUTCOMES;
D O I
10.1097/INF.0b013e3181d1e989
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: While the impact of HAART on growth in children is well established, the influence of prior nutritional status on the response to HAART is not well known. Methods: A retrospective study was conducted on 120 children in South Africa. Patients were divided into 3 groups (normal, moderately underweight, and severely underweight) based on weight-for-age z-scores (WAZ). Age, weight, height, CD4 cell percentage, and viral load were recorded at initiation of HAART and after 24 months of therapy. Data were analyzed using t-tests, chi(2) tests, and one-way ANOVA. Results: At baseline, 58% of children were normal weight, 18% moderately underweight, and 23% severely underweight. After 24 months of HAART, WAZ improved significantly in moderately and severely underweight patient groups compared with the normal group. Height-for-age z-scores (HAZ) increased in all 3 groups with severely underweight children gaining more height than normal weight counterparts. Weight-for-height z-scores (WHZ) normalized in the severely underweight group. Mean CD4 cell percentages increased significantly in all 3 groups while viral loads decreased significantly in all groups with no differences among the groups at the end of 24 months of therapy. Of the entire cohort, 75% achieved undetectable HIV RNA viral loads. Conclusions: Underlying malnutrition does not adversely affect growth, immunologic or virologic response to HAART in HIV-infected children. Underweight children exhibit an equally robust response to treatment as their well-nourished peers.
引用
收藏
页码:511 / 513
页数:3
相关论文
共 25 条
[11]   Two-Year Outcomes of Children on Non-Nucleoside Reverse Transcriptase Inhibitor and Protease Inhibitor Regimens in a South African Pediatric Antiretroviral Program [J].
Jaspan, Heather B. ;
Berrisford, Alison E. ;
Boulle, Andrew M. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (11) :993-998
[12]   EFFECT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON THE GROWTH OF YOUNG-CHILDREN [J].
MCKINNEY, RE ;
ROBERTSON, JWR .
JOURNAL OF PEDIATRICS, 1993, 123 (04) :579-582
[13]  
MCKINNEY RE, 1995, SEMIN PEDIAT INFECT, V6, P32, DOI DOI 10.1016/S1045-1870(05)80021-4
[14]   Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy [J].
Miller, TL .
AIDS, 2003, 17 :S130-S140
[15]   Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy [J].
Nachman, SA ;
Lindsey, JC ;
Moye, J ;
Stanley, KE ;
Johnson, GM ;
Krogstad, PA ;
Wiznia, AA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (04) :352-357
[16]   Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program [J].
Puthanakit, T ;
Oberdorfer, A ;
Akarathum, N ;
Kanjanavanit, S ;
Wannarit, P ;
Sirisanthana, T ;
Sirisanthana, V .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (01) :100-107
[17]   Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa [J].
Reddi A. ;
Leeper S.C. ;
Grobler A.C. ;
Geddes R. ;
France K.H. ;
Dorse G.L. ;
Vlok W.J. ;
Mntambo M. ;
Thomas M. ;
Nixon K. ;
Holst H.L. ;
Karim Q.A. ;
Rollins N.C. ;
Coovadia H.M. ;
Giddy J. .
BMC Pediatrics, 7 (1)
[18]  
Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1
[19]   Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands [J].
van Rossum, AMC ;
Niesters, HGM ;
Geelen, SPM ;
Scherpbier, HJ ;
Hartwig, NG ;
Weemaes, CMR ;
Veerman, AJP ;
Suur, MH ;
de Graeff-Meeder, ER ;
Slicker, WAT ;
Hop, WCJ ;
Osterhaus, ADME ;
Burger, DM ;
de Groot, R .
JOURNAL OF PEDIATRICS, 2000, 136 (06) :780-788
[20]   Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth [J].
Verweel, G ;
van Rossum, AMC ;
Hartwig, NG ;
Wolfs, TFW ;
Scherpbier, HJ ;
de Groot, R .
PEDIATRICS, 2002, 109 (02) :E25